Physician profile
Heather M Feldman
NPI 1306154513
$2,149.01
in general payments reported to CMS, 2019-2025
20 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $544 · 2023: $566 · 2024: $122 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $776.87 | 2021-2025 | Fasenra, Calquence, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.26 | 2021-2023 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $178.55 | 2021-2023 | Nucala, Trelegy Ellipta |
| Covis Pharma Gmbh | $127.94 | 2021-2022 | |
| Incyte Corporation | $121.84 | 2024 | Jakafi |
| Takeda Pharmaceuticals U.S.A., INC. | $112.21 | 2021-2023 | Cuvitru |
| Pharmacosmos Therapeutics INC. | $104.03 | 2025 | Monoferric |
| Inari Medical, INC. | $101.09 | 2022 | |
| Genzyme Corporation | $90.87 | 2022-2023 | |
| Mylan Specialty L.P. | $90.50 | 2021-2023 | Yupelri |
| Amgen INC. | $48.42 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $40.89 | 2021-2022 | |
| Pfizer INC. | $33.93 | 2023 | |
| Electromed, INC. | $20.38 | 2023 | Smartvest |
| Mallinckrodt Hospital Products INC. | $19.94 | 2023 | Acthar |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.15 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.75 | 2021 | |
| Merck Sharp & Dohme LLC | $17.60 | 2023 | |
| Sanofi Pasteur INC. | $15.72 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.